Laura Smith
About Laura Smith
Laura Smith is a Scientist at Bristol-Myers Squibb with over 20 years of experience in upstream process development, specializing in cell culture and fermentation process optimization.
Current Role at Bristol-Myers Squibb
Laura Smith currently serves as a Scientist at Bristol-Myers Squibb in the Greater Boston Area. Her role includes leading the optimization of recombinant protein manufacturing processes across various expression systems such as microbial, mammalian, and insect. She brings over 20 years of experience in upstream process development, focusing on cell culture and fermentation process optimization to the company.
Previous Experience at ZymoGenetics, Inc.
Laura Smith has had multiple roles at ZymoGenetics, Inc., including Scientist, Associate Scientist, and Research Associate in Bio-Process Development. She has extensive experience spanning from 1994 to 2011, contributing to her deep expertise in process development, cloning, and preparation of cell banks, as well as process optimization.
Senior Process Development Engineer at Dendreon
From 2009 to 2011, Laura Smith worked as a Senior Process Development Engineer at Dendreon. In this role, she was responsible for process development and optimization, utilizing her skills in technical transfer and cGMP manufacturing to enhance the company's bioprocesses.
Educational Background in Biology
Laura Smith holds a Bachelor's of Science degree in Biology from Washington State University. Her academic foundation in biological sciences has been the cornerstone of her career in biotechnology and process development within the pharmaceutical industry.
Expertise in Process Development and Technical Transfer
With over 20 years of experience, Laura Smith excels in upstream process development, focusing on cell culture and fermentation. She has demonstrated expertise in cloning, preparation of cell banks, and technical transfer. Her specialization includes soluble, periplasmic, and insoluble expression, as well as process characterization, range finding, and robustness studies. Additionally, she has experience in primary recovery and technical writing, making her a versatile asset in the biotechnology field.